DDC
PGNX

DF Dent & Co’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

DF Dent & Co’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,600
Closed -$116K – 245
2018
Q1 		$116K Buy
+15,600
New +$116K ﹤0.01% 234